Skip to main content
    M

    Milestone Pharmaceuticals Inc (MIST)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.36
    -0.16 (-29.81%)

    Market Cap: $64.74M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Milestone Pharmaceuticals Inc (MIST) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Milestone Pharmaceuticals are Pmv Pharmaceuticals (PMVP), Tenaya Therapeutics (TNYA) and Tenax Therapeutics (TENX). By market cap, Milestone Pharmaceuticals ranks 7th of the 13 companies on this page; OUTLOOK THERAPEUTICS INC (OTLK) is the largest at $100.54M.

    Peer Comparison

    MIST's ROIC of -133.9% is above the peer median of -188.5%, and its revenue growth of -100.0% is below the median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Milestone Pharmaceuticals (MIST)$64.74MN/A8.6x0.0%-133.9%-100.0%0.00%
    Pmv Pharmaceuticals Inc (PMVP)$95.93MN/AN/A0.0%N/A0.0%0.00%
    Tenaya Therapeutics Inc (TNYA)$79.59MN/AN/A0.0%N/A0.0%0.00%
    Tenax Therapeutics Inc (TENX)$73.77MN/AN/A0.0%N/A0.0%0.00%
    Biomea Fusion Inc (BMEA)$42.31MN/AN/A0.0%N/A0.0%0.00%
    Mink Therapeutics Inc (INKT)$47.95MN/A236.3x0.0%N/A0.0%0.00%
    Mereo BioPharma Group PLC ADR (MREO)$49.11MN/A61.3x0.0%-116.6%0.0%0.00%
    Rani Therapeutics Holdings Inc (RANI)$60.78MN/A16.3x0.0%N/A893.0%0.00%
    OUTLOOK THERAPEUTICS INC (OTLK)$100.54MN/AN/A0.0%-776.9%-99.4%0.00%
    Oncolytics Biotech Inc (ONCY)$48.51MN/AN/A0.0%N/A0.0%0.00%
    Corbus Pharmaceuticals Holding (CRBP)$69.86MN/A13.9x0.0%-106.7%-100.0%0.00%
    Grace Therapeutics, Inc. (GRCE)$38.08MN/AN/A0.0%N/A0.0%0.00%
    Neumora Therapeutics, Inc. (NMRA)$80.59MN/AN/A0.0%-260.5%0.0%0.00%
    Peer median$65.32MN/A38.8x0.0%-188.5%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Milestone Pharmaceuticals, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Pmv Pharmaceuticals Inc (PMVP)
    PMV Pharmaceuticals, Inc., a precision oncology company, is dedicated to the discovery and development of small molecule tumor agnostic therapies for p53...
    PMVP competitors
    Tenaya Therapeutics Inc (TNYA)
    Tenaya Therapeutics Inc. is a pioneering clinical-stage biotechnology firm that is revolutionizing the treatment of heart disease through its proprietary...
    TNYA competitors
    Tenax Therapeutics Inc (TENX)
    Tenax Therapeutics, Inc., a specialty pharmaceutical company, is dedicated to identifying, developing...
    TENX competitors
    Biomea Fusion Inc (BMEA)
    Biomea Fusion, Inc., a biopharmaceutical company, is focused on the discovery, development and commercialization of irreversible small molecules to treat...
    BMEA competitors
    Mink Therapeutics Inc (INKT)
    MiNK Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of allogeneic...
    INKT competitors
    Mereo BioPharma Group PLC ADR (MREO)
    Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops and markets therapeutic products for the treatment of oncology and rare diseases...
    MREO competitors
    Rani Therapeutics Holdings Inc (RANI)
    Rani Therapeutics Holdings Inc. is an innovative biotechnology company transforming the landscape of drug delivery with its proprietary RaniPill™ technology...
    RANI competitors
    OUTLOOK THERAPEUTICS INC (OTLK)
    Outlook Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic...
    OTLK competitors
    Oncolytics Biotech Inc (ONCY)
    Oncolytics Biotech Inc., a developing-stage biopharmaceutical company, focuses on the discovery and development of pharmaceuticals for the treatment of cancer.
    ONCY competitors
    Corbus Pharmaceuticals Holding (CRBP)
    Corbus Pharmaceuticals Holdings, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of novel therapies that target...
    CRBP competitors
    Grace Therapeutics, Inc. (GRCE)
    Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.
    GRCE competitors
    Neumora Therapeutics, Inc. (NMRA)
    Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases...
    NMRA competitors

    Frequently Asked Questions About MIST

    Who are Milestone Pharmaceuticals' main competitors?

    The companies most similar to Milestone Pharmaceuticals include Pmv Pharmaceuticals (PMVP), Tenaya Therapeutics (TNYA), Tenax Therapeutics (TENX), Biomea Fusion (BMEA) and Mink Therapeutics (INKT), listed from the closest match.

    Who is Milestone Pharmaceuticals' biggest competitor?

    OUTLOOK THERAPEUTICS INC (OTLK) is the largest of the similar companies at $100.54M; Pmv Pharmaceuticals (PMVP) is the closest match by business profile, size, sector and industry.

    How does MIST stock compare with its competitors?

    MIST's P/S is 8.6x against a peer median of 38.8x; its net margin is 0.0% against a peer median of 0.0%.

    Which of Milestone Pharmaceuticals' competitors pays a higher dividend?

    Milestone Pharmaceuticals pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Milestone Pharmaceuticals bigger than its competitors?

    No. Milestone Pharmaceuticals is 7th by market cap among the 13 companies on this page; the largest is OUTLOOK THERAPEUTICS INC (OTLK) at $100.54M.